CCGB's revenue expected to grow more than 23% YoY

On 16 Jan., Chenguang Biotech Group Co., Ltd. (CCGB) released its 2022 financial forecast. Sales of its main products such as capsanthin and lutein increased. CCGB's projections for 2022 results:Revenue: USD863.62 million–USD921.19 million (RMB...

Sweeteners China News 202301

www.cnchemicals.com